Zesen Ma’s research while affiliated with University of Science and Technology of China and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (3)


Optimizing Peptide-Conjugated Lipid Nanoparticles for Efficient siRNA Delivery across the Blood–Brain Barrier and Treatment of Glioblastoma Multiforme
  • Article

March 2025

·

16 Reads

ACS Chemical Biology

Haiyang Tong

·

Zesen Ma

·

Jin Yu

·

[...]

·



The schematic of the isometric channel-size enlarging strategy for scalable synthesis of LNPs. This strategy involves the use of microfluidic mixers with the same structure but different channel sizes at different stages of LNP synthesis. Small mixer can be used in drug development to achieve precise parameter tuning for optimal formulation while minimizing the consumption of expensive RNA reagents. Large mixer allows for higher throughput and can be used in clinical applications and industrial production to synthesize LNPs with consistent properties.
Characterization of mixing properties and fine tuning of lipid nanoparticle size using an inertial mixer. (a) Mixing time characterization as a function of total flow rate for different flow rate ratios. The solid line represents complete mixing, while the dashed line represents incomplete mixing. In this experiment, a mixer with a channel-size of 250 μm was used. (b) Average particle size of C12-200 LNPs and neutral LNPs at different mixing times, obtained using the 250 μm mixer with a FRR of 5:1. Results represent mean ± SD of three independent batches.
Synthesis of LNPs with consistent particle size and size distribution at same mixing times using different channel-size mixers. (a) In this experiment, we designed and prepared four channel-size mixers for LNP synthesis to satisfy different production requirements. (b–c) Two LNP formulations to prove the universality of our method and the FRR was set at 5:1. The average particle size and PDI of (b) C12-200 LNPs and (c) neutral LNPs at the same mixing time were measured to prove the consistency. Results represent mean ± SD of three independent batches. Non-significant differences are abbreviated as “ns”.
The relationships among mixing time, Reynolds number, total flow rate and particle size for different channel-size mixers. (a) The relationship between mixing time and Reynolds number across different channel-size mixers. (b) The relationship between total flow rate and mixing time across different channel-size mixers. The calculated flow rates required to synthesize (c) C12-200 LNPs and (d) neutral LNPs of varying particle sizes using the four channel-size mixers. The dashed lines indicate the values that are theoretically achievable, but are limited by the strength of the PDMS chip in this experiment. Results represent mean ± SD of three independent batches.
Evaluation of the physical properties of C12-200 LNPs encapsulating siRNA synthesized at three flow rates under the same mixing time of 10 ms. Average particle size, PDI and (c) size distribution profiles of the LNPs (a) before and (b) after purification. (d) siRNA encapsulation efficiency of the LNPs after purification. Three mixers with channel-size of 100, 250 and 500 μm were used in this experiment and the flow rates were set at 0.8, 4.7 and 18.0 mL/min, respectively. Results represent mean ± SD of three independent batches. Non-significant differences are shown as “ns”.

+1

Scalable synthesis of lipid nanoparticles for nucleic acid drug delivery using an isometric channel-size enlarging strategy
  • Article
  • Full-text available

April 2024

·

73 Reads

·

5 Citations

Lipid nanoparticles (LNPs) have emerged as highly effective delivery systems for nucleic acid-based therapeutics. However, the broad clinical translation of LNP-based drugs is hampered by the lack of robust and scalable synthesis techniques that can consistently produce formulations from early development to clinical application. In this work, we proposed a method to achieve scalable synthesis of LNPs by scaling inertial microfluidic mixers isometrically in three dimensions. Moreover, a theoretical predictive method, which controls the mixing time to be equal across different chips, is developed to ensure consistent particle size and size distribution of the synthesized LNPs. LNPs loaded with small interfering RNA (siRNA) were synthesized at different flow rates, exhibiting consistent physical properties, including particle size, size distribution and encapsulation efficiency. This work provides a practical approach for scalable synthesis of LNPs consistently, offering the potential to accelerate the transition of nucleic acid drug development into clinical application.

Download

Citations (1)


... A) Schematic of the isometric channel-size enlarging strategy (as a SAR mixer) for the synthesis of LNPs. The image is reproduced with permission from Ref.58 , copyright 2023 Tsinghua University Press. (B) Synthesis of LNPs with consistent particle size and PDI at the same mixing times using different channel-size mixers. ...

Reference:

Research Strategies for Precise Manipulation of Micro/Nanoparticle Drug Delivery Systems Using Microfluidic Technology: A Review
Scalable synthesis of lipid nanoparticles for nucleic acid drug delivery using an isometric channel-size enlarging strategy